BCR signaling is directly affected by frequent mutations in CD79A (immunoglobulin α) and CD79B (immunoglobulin β)-mainly CD79B-which occur in approximately 20% of patients with ABC-DLBCL [94]. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.